Oric Pharmaceuticals
Kevin Sun is currently the Director of IT Enterprise Applications at ORIC Pharmaceuticals Inc. Kevin previously worked as an Associate Director, IT Business Partner at Bristol Myers Squibb from November 2020 to August 2021. Prior to that, they held the same position at MyoKardia from August 2019 to August 2021. Kevin also worked as an IT Applications Manager at Five Prime Therapeutics, Inc. from August 2017 to August 2019. Before that, they worked as a Business Systems Specialist, Expert at Pacific Gas and Electric Company from August 2016 to July 2017 and as an Applications Analyst at Depomed, Inc. from March 2016 to August 2016. Additionally, they have experience as an IT Supervisor and IT Business Support Analyst at Simpson Strong-Tie from January 2011 to January 2016.
Kevin Sun attended UCLA from 2005 to 2009, where they earned a B.A. degree. The field of study they pursued during this time is unknown due to the lack of available information.
This person is not in the org chart
Oric Pharmaceuticals
ORIC Pharmaceuticals is a privately held, clinical-stage oncology company focused on making cancer treatments more effective by addressing mechanisms of resistance. ORIC's lead asset, ORIC-101, is a potent and selective small-molecule antagonist of the glucocorticoid receptor. ORIC's pipeline targets other undisclosed mechanisms of oncology therapy resistance. ORIC's scientific founders are Drs. Charles Sawyers, MD, and Scott Lowe, PhD, who have strong records of discovering innovative treatments and targets in cancer. The company has assembled strong leadership and scientific teams and a board with extensive experience in drug development and financing. ORIC is funded by leading biotechnology investors, including The Column Group, Topspin Partners, OrbiMed Advisors, EcoR1 Capital, Fidelity Management & Research Company, Trinitas Capital, Foresite Capital, Taiho Ventures, Memorial Sloan Kettering, Kravis Investment Partners, NS Investment and City Hill Ventures. ORIC is headquartered in South San Francisco, California.